Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: KPRX) Delayed: 2.59 -0.01 (0.38%)
Previous Close $2.60    52 Week High
Open $2.54    52 Week Low
Day High $2.59    P/E N/A 
Day Low $2.54    EPS
Volume 3,957